Encompass Health Co. (NYSE:EHC) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its position in shares of Encompass Health Co. (NYSE:EHC) by 302.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 578,283 shares of the company’s stock after acquiring an additional 434,553 shares during the period. Envestnet Asset Management Inc. owned about 0.58% of Encompass Health worth $8,435,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of EHC. US Bancorp DE lifted its stake in Encompass Health by 66.4% during the 1st quarter. US Bancorp DE now owns 9,336 shares of the company’s stock worth $664,000 after acquiring an additional 3,725 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in Encompass Health during the 1st quarter worth about $318,000. PNC Financial Services Group Inc. increased its holdings in Encompass Health by 10.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock worth $622,000 after purchasing an additional 834 shares during the period. Bank of Montreal Can increased its holdings in Encompass Health by 1.5% during the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock worth $806,000 after purchasing an additional 173 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Encompass Health by 10.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock worth $2,593,000 after purchasing an additional 3,477 shares during the period. Institutional investors and hedge funds own 92.66% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Stephens reiterated an “overweight” rating and issued a $78.00 price objective on shares of Encompass Health in a report on Thursday, July 20th. Mizuho increased their price objective on Encompass Health from $74.00 to $77.00 and gave the company a “buy” rating in a report on Thursday, August 3rd. Raymond James increased their price objective on Encompass Health from $80.00 to $85.00 and gave the company a “strong-buy” rating in a report on Thursday, August 3rd. StockNews.com assumed coverage on Encompass Health in a report on Thursday, August 17th. They issued a “buy” rating on the stock. Finally, Barclays increased their price objective on Encompass Health from $61.00 to $71.00 and gave the company an “equal weight” rating in a report on Thursday, August 3rd. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $77.60.

Encompass Health Stock Down 0.1 %

Encompass Health stock opened at $70.32 on Thursday. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.34. The stock has a 50 day moving average of $68.71 and a two-hundred day moving average of $63.10. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 22.61, a PEG ratio of 1.74 and a beta of 1.03. Encompass Health Co. has a twelve month low of $45.11 and a twelve month high of $72.06.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.74 by $0.21. The business had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Encompass Health had a return on equity of 18.26% and a net margin of 6.86%. As a group, research analysts expect that Encompass Health Co. will post 3.45 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be issued a dividend of $0.15 per share. The ex-dividend date is Friday, September 29th. This represents a $0.60 annualized dividend and a yield of 0.85%. Encompass Health’s dividend payout ratio is presently 19.29%.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 25,330 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $71.06, for a total transaction of $1,799,949.80. Following the completion of the transaction, the chief executive officer now owns 497,405 shares of the company’s stock, valued at $35,345,599.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Encompass Health news, CEO Mark J. Tarr sold 25,330 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $71.06, for a total transaction of $1,799,949.80. Following the completion of the transaction, the chief executive officer now owns 497,405 shares of the company’s stock, valued at $35,345,599.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Elissa Joy Charbonneau sold 8,294 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $69.58, for a total value of $577,096.52. Following the transaction, the insider now directly owns 23,081 shares of the company’s stock, valued at approximately $1,605,975.98. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.